PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 15319348-1 2004 Both UDP-glucuronosyltransferase 2B4 (UGT2B4) and UGT2B7 are expressed mainly in the human liver and have several overlapping substrates; e.g., catechol estrogens, bile acids, codeine, and carvedilol. catechol 144-152 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 50-56 11159850-10 2001 UGT2B7 was demonstrated to glucuronidate estrogens, catechol estrogens, and androstane-3alpha,17beta-diol more efficiently than any other human UGTB isoform. catechol 52-60 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 0-6 9848110-3 1998 Three human liver UDP-glucuronosyltransferases, UGT2B7, UGT1A1, and UGT1A3, have been shown to catalyze the glucuronidation of catechol estrogens and lead to their enhanced elimination via urine or bile. catechol 127-135 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 48-54 9848110-7 1998 UGT2B7(H) catalyzed estrogen catechol glucuronidation with efficiencies similar to UGT2B7(Y). catechol 29-37 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 0-6 9848110-8 1998 Flunitrazepam (FNZ), a competitive inhibitor of morphine glucuronidation in hepatic microsomes, competitively inhibited catechol estrogen glucuronidation catalyzed by UGT2B7(Y), UGT1A1, and UGT1A3. catechol 120-128 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 167-173 9443856-3 1998 UGT2B7 has been shown to catalyze NSAIDs, catechol estrogens, and morphine-3- and -6-glucuronidation. catechol 42-50 UDP glucuronosyltransferase family 2 member B7 Homo sapiens 0-6